Originally published as Covington E-Alert on November 10, 2010
The UK government will consult in the coming year on proposals to move the UK’s National Health Service (NHS) towards a value-based system of pricing medicines from 2014. While official details are yet to be published, it is expected that doctors will be given powers to decide whether or not to make drugs available to patients. This would effectively remove the ability of the National Institute for Health and Clinical Excellence (NICE), the health technology appraisal body for England and Wales, to recommend which drugs can be reimbursed on the NHS. Rather, NICE is to take on an advisory role regarding the amount that the NHS would be prepared to pay.
Read the complete article here